Co-Founder & CFO
ana.seco @ aptusbiotech.com
Graduate in Economy, MBA IESE Business School, Co-Founder of AptusBiotech and AptaTargets. Expert in Biotech Management. She is the Sole Administrator and Financial Manager of the company.
victor.m.gonzalez @ aptusbiotech.com
g.fernandez @ aptusbiotech.com
Graduated in Chemistry, specialty Biochemistry and Molecular Biology (UAM 1997) and PhD. in CC. Chemistry, Biomedicine program (UAH 2002), I have developed my professional career focused on therapy and human diagnosisLeer más
Project Manager and Head of Gender Policy
garciasaa @ aptusbiotech.com
Graduated in Chemistry at the Universidad Complutense de Madrid in 1998. She obtained the PH.D degree in 2004 at the Universidad Complutense of Madrid working with genes involved in cell differentiationLeer más
celia.pinto @ aptusbiotech.com
Degree in Biology (2009), Master of Health Analysis at the Complutense University (2013).and PhD. in Biology at UAH (2019). More than 10 years of experience in aptamers. She has been focused on the development of the aptamer apMNKQ2Leer más
ana.salgado @ aptusbiotech.com
Graduated in Biology (UAM) and MsC in genetics and cell biology (UAM, UAH, UCM), she is currently undertaking the PhD in Biology at the UAM.She has more than 5 years of experience in aptamers. She owns a CAM Doctor Industrial fellowshipLeer más
laura.herraiz @ aptusbiotech.com
Bachelor in Pharmacy from UCM, MSc in Microbiology by Radboud University (The Netherlands). Experienced researcher in several labs in Germany and The Netherlands.
m.barragan @ aptusbiotech.com
Senior Technician in Pathological
Anatomy and Cytology and 7 years of
experience in different aptamer
Director of the Baselga Oncologic Institute (IOB), Clinical Researcher of the Breast Cancer Research Program of the Vall d’Hebrón Oncology Institute of Barcelona. Actively involved in the development of 4 candidates drugs against metastatic breast cancer in Europe from which approved: pertuzumab, eribulina y everolimus. National Prize of Medicine 2021
Leader of the Aptamer Group at IRYCIS. PhD. in Biochemistry at UAM. Postdoctoral researcher at UAH. Expert in aptamers, signalling and molecular biology of cancer as well as ischemic pathologies.